Drug intelligence / Profile preview

Keluoxin

Development stage
Phase 4
Lead developer
Sichuan Jishengtang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Keluoxin is a Chinese patent medicine formulated as an oral capsule and used primarily for the treatment of diabetic kidney disease (DKD) and diabetic nephropathy. It is composed of six natural herbs based on traditional Chinese medicine principles to invigorate qi and nourish yin, activate blood circulation, and eliminate blood stasis. Mechanistic studies suggest that Keluoxin exerts its effects by regulating glucose and lipid metabolism, improving renal hemodynamics, reducing proteinuria (urinry albumin excretion), protecting podocytes via enhanced autophagy and reduced injury, inhibiting inflammatory responses in the kidney (including modulation of eNOS/NOX4/NF-κB pathways), reducing oxidative stress, inhibiting tissue inhibitor of matrix metalloproteinase-1 overexpression while increasing matrix metalloprotein-9 expression in renal tissue. Clinical trials have shown that it can reduce proteinuria and improve estimated glomerular filtration rate when used alone or in combination with Western medicines such as angiotensin receptor blockers[1][2][5][7][10].

Brand names
KeluoxinKeluoxin capsuleKLXKLXC
Other names
Keluoxin capsuleKLXKLXC
02

Targets

NOX4 (NADPH oxidase 4)MMP9 (Matrix metalloproteinase-9)TIMP1 (Metalloproteinase inhibitor 1)NOS3 (eNOS)NF-κB

Beyond the preview

Go deeper on Keluoxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keluoxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call